Loading...
Diabetes mellitus is a relentlessly evolving pandemic and a significant public health problem in recent decades. Diabetes disturbs millions of people worldwide, with a significant adverse effect on the quality of their lives.
Gestational diabetes mellitus (GDM) is diabetes that appears during pregnancy, presenting an opportunity for early testing and care to prevent non-communicable diseases (NCDs).
Glycemic control reduces the risk of cardiovascular complications among people with diabetes. However, the current status of glycemic control is uncertain among Iranian people with diabetes. This study aims to systematically review the studies on the status of glycemic control among people with type 2 diabetes in Iran.
Gestational diabetes mellitus (GDM) is commonly noted during the second trimester of pregnancy. There is limited clinical evidence for the diagnosis of GDM during the third trimester of pregnancy, particularly in Indian pregnant women.
To investigate the prevalence of gestational diabetes mellitus (GDM) and its associated factors in Shenzhen, China.
Insulin therapy though time-tested and effective option requires a certain degree of expertise (or training) and storage precautions. Metformin is cheap, orally taken, and does not cause hypoglycemia. Controversy exists regarding safety and efficacy of metformin therapy during pregnancy.
Gestational diabetes mellitus (GDM) is a health problem that threatens maternal and infant health with increasing prevalence in the world. Patient education is very effective in managing the disease.
We aimed to assess atrial conduction time and P-wave dispersion (PWD) in gestational diabetes mellitus (GDM) patients.
Insulin degludec/insulin aspart (IDegAsp) is the first dual combination that acts separately (basal and prandial actions). Different insulin regimens can be switched to IDegAsp. Several studies have been conducted evaluating the effectiveness and safety of IDegAsp. The purpose of this real-life study was to determine the effects of IDegAsp on metabolic control and hypoglycemia in patients who were switched from different insulin regimens to IDegAsp therapy.
Continuous glucose monitoring (CGM) can help manage diabetes mellitus (DM) and prevent hypoglycemia. This study aimed to evaluate the performance and usability of a novel SiJoy GS1 CGM system.
The study aimed to evaluate the fear of hypoglycemia (FoH), nutritional factors, and behavioral strategies before exercise in children and adolescents with type 1 diabetes (T1D)
There are very few studies in which retinopathy is determined by fundus fluorescein angiography (FFA) in prediabetics. We aimed to determine the frequency of retinopathy with a sensitive method and its relation to nephropathy in the prediabetic population.
Diabetes mellitus (DM) had one of the highest global disease burdens and is associated with premature morbidity, mortality, and reduced life expectancy. There has been little study regarding mortality and years of life lost attributable to DM in low-and-middle income countries.
Early menarche and premature menopause are of public health concern since they are known to be associated with chronic disease susceptibility, including diabetes
Maternally inherited diabetes and deafness (MIDD) is a rare form of diabetes, caused by a mutation in the mitochondrial DNA (mtDNA) which impairs mitochondrial function by decreasing the efficiency of the Leucine transfer ribonucleic acid (tRNA) in adding amino acids to developing proteins.
Gestational diabetes mellitus (GDM) is any degree of glucose intolerance diagnosed during pregnancy. Metabolic abnormalities in GDM are associated with pancreatic -cell destruction and decreased insulin sensitivity. Carbohydrate-responsive element-binding protein (ChREBP) and sterol regulatory element-binding protein-1c (SREBP-1c) are two transcription factors that play a key role in carbohydrate and lipid metabolism homeostasis. Our aim in this study was to elucidate the role of these proteins in GDM
Zonulin, carnitine, choline, -butyrobetaine (-BB), and trimethylamine-N-oxide (TMAO) are intricately involved in metabolic anomalies and type 2 diabetes mellitus (T2D). This study aimed to compare and correlate the plasma levels of zonulin, carnitine, choline, -butyrobetaine, and TMAO, along with the adiposity, atherogenicity, surrogate insulin resistance (sIR), and proinflammatory hematological indices of newly diagnosed drug-naive prediabetic and diabetic patients vs. apparently healthy normoglycemic controls
Type I diabetes mellitus can lead to the development of cognitive dysfunction and anxiety due to chronic hyperglycemia, recurrent hypoglycemia, and micro - and macrovascular complications. It is known that oxytocin and copeptin have effects on neuropsychiatric activities such as learning, memory, and social adaptation and have anxiolytic properties. In this study, we aimed to search the relationship between oxytocin and copeptin levels and cognition and anxiety in patients with type I diabetes mellitus.
As a clinical and non-invasive tool, the AGE Reader measures skin autofluorescence (SAF) to estimate the accumulation of advanced glycation end products (AGEs) in the skin. Accumulation of AGEs has been implicated in several inflammation-associated diseases, including diabetes and cardio-metabolic diseases. This study aimed to assess SAF in subjects with and without cardiovascular risk (CVR) factors and examine the association between SAF and various bio-clinical parameters.
Inflammatory markers like tumor necrosis factor- (TNF-) and high-sensitivity C-reactive protein (hsCRP) have been thought to be associated with diabetes mellitus (DM). But their role in the development of diabetes in young is yet to be established
Rajeev Chawla, North Delhi Diabetes Centre, Delhi
The human mind is always full of questions and research is the tool that helps us find answers. Research is simplistically described as the creation of new knowledge &/or use of existing knowledge from a unique scientific perspective so as to generate newer innovations and outcomes. As IJDDC goes online we present to you a great opportunity to showcase your original research and innovations to a whole new ecosystem with a far greater outreach - handily available on all ur devices !! No matter where you are..our app brings you the latest science on your fingertips anytime you need it !!
